In a meta-analysis of 33 randomized controlled trials, Makani and colleagues 1 compared efficacy and safety outcomes in patients treated by blockade of the renin–angiotensin–aldosterone system (RAAS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback